Quick Takeaways
- David A. Rosa has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $818,740.
- Recent insider filing activity is available below.
Insider Trading & Ownership of David A. Rosa
- Location
- Minnetonka, MN
- Summary
- The estimated net worth of David A. Rosa is at least $818,740 dollars as of 01 Apr 2026. David A. Rosa is the CEO and President, Director of NEUROONE MEDICAL TECHNOLOGIES Corp and owns shares of NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) stock worth about $818.7K.
- Signature
- /s/ Emily Johns, by Power of Attorney
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow David A. Rosa and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: NEUROONE MEDICAL TECHNOLOGIES Corp ($818,740).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of David A. Rosa
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | CEO and President, Director | $818,740 | 31 Mar 2026 | ||
| BRTX | BioRestorative Therapies, Inc. | Director | 14 Feb 2025 | |||
| BTCY | BIOTRICITY INC. | Director | 12 Mar 2023 | |||
| HCTI | Healthcare Triangle, Inc. | Director | 12 Mar 2024 |
Insider Transactions Reported by David A. Rosa:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.